Hypertension · 2010 · 83 citations · 29 references
Life SciencesNeurobiologyPhysiologyApoptosisCell SignalingSignal TransductionApoptotic SignalingBlood Pressure RegulationCardiovascular Molecular PhysiologyCardiovascular PhysiologyIntrinsic Apoptotic PathwayC-jun N-terminal Kinase SignalingCaspase SignalingExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingHypertension PathophysiologyJun N-terminal Kinase SignalingP38 Mitogen-activated Protein Kinase SignalingRas-mitogen-activated Protein Kinase Signaling
In the rostral ventrolateral medulla (RVLM), angiotensin II-derived superoxide anions, which increase sympathetic nerve activity, induce a pressor response by activating the p38 mitogen-activated protein kinase (p38 MAPK) and extracellular signal-regulated kinase (ERK) pathway. The small G protein Ras mediates a caspase-3-dependent apoptotic pathway through p38 MAPK, ERK, and c-Jun N-terminal kinase. We hypothesized that angiotensin II type 1 receptors activate caspase-3 through the Ras/p38 MAPK/ERK/c-Jun N-terminal kinase pathway in the RVLM and that this pathway is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats (SHRSP), a model of human hypertension. The activities of Ras, p38 MAPK, ERK, and caspase-3 in the RVLM were significantly higher in SHRSP (14 to 16 weeks old) than in age-matched Wistar-Kyoto rats (WKY). The mitochondrial apoptotic proteins Bax and Bad in the RVLM were significantly increased in SHRSP compared with WKY. c-Jun N-terminal kinase activity did not differ between SHRSP and WKY. In SHRSP, intracerebroventricular infusion of a Ras inhibitor significantly reduced sympathetic nerve activity and improved baroreflex sensitivity, partially because of inhibition of the Ras/p38 MAPK/ERK, Bax, Bad, and caspase-3 pathway in the RVLM. Intracerebroventricular infusion of a caspase-3 inhibitor also inhibited sympathetic nerve activity and improved baroreflex sensitivity in SHRSP. Intracerebroventricular infusion of an angiotensin II type 1 receptor blocker in SHRSP partially inhibited the Ras/p38 MAPK/ERK, Bax, Bad, and caspase-3 pathway in the RVLM. These findings suggest that in SHRSP, angiotensin II type 1 receptor-activated caspase-3 acting through the Ras/p38 MAPK/ERK pathway in the RVLM might be involved in sympathoexcitation, which in turn plays a crucial role in the pathogenesis of hypertension.
29
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
Manuel Serrano, Athena W. Lin, Mila E. McCurrach et al. · Cell · 1997 · 5.1K citations · Full text
Medicine, Cell Biology, Oncology +10
Development of a Strain of Spontaneously Hypertensive Rats
Kôzô Okamoto, Kyuzo Aoki · Japanese Circulation Journal · 1963 · 2.5K citations
Takuya Kishi, Yoshitaka Hirooka, Yoshikuni Kimura et al. · Circulation · 2004 · 307 citations · Full text
Cooperating oncogenes converge to regulate cyclin/cdk complexes.
Alison C. Lloyd, F Obermüller, S Staddon et al. · Genes & Development · 1997 · 226 citations · Full text